^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IDH1R132H peptide vaccine

    i
    Associations
    News

    Trials

    Company:
    German Cancer Research Center
    Drug class:
    Immunostimulant
    Related drugs:
    Associations
    News

    Trials

    Apply
    AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma (AMPLIFY-NEOVAC) (NCT03893903)
    Phase 1
    German Cancer Research Center
    Active, not recruiting
    Last update posted :
    06/05/2024
    Initiation :
    10/19/2018
    Primary completion :
    09/01/2024
    Completion :
    12/01/2024
    ATRX
    |
    IDH1 R132
    |
    Bavencio (avelumab) • IDH1R132H peptide vaccine
    Phase I Trial of IDH1 Peptide Vaccine in IDH1R132H-mutated Grade III-IV Gliomas (NOA-16) (NCT02454634)
    Phase 1
    National Center for Tumor Diseases, Heidelberg
    Completed
    Last update posted :
    11/07/2018
    Initiation :
    06/01/2015
    Primary completion :
    09/19/2017
    Completion :
    09/19/2017
    IDH1 • IFNG • ATRX
    |
    IDH1 R132H • IDH1 R132
    |
    IDH1R132H peptide vaccine